ZOLBETUXIMAB
UNII TF5MPQ8WGY

Substance Identification & Data

This profile provides standardized clinical and technical data for Zolbetuximab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TF5MPQ8WGY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1496553-00-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

TF5MPQ8WGY

CAS Registry Number

1496553-00-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZOLBETUXIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

TF5MPQ8WGY

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C85475

National Cancer Institute reference terminology for clinical and research data.

INN ID

10473

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-138

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zolbetuximab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZOLBETUXIMAB

ZOLBETUXIMAB-CLZB

Common Names & Synonyms

CLAUDIXIMAB

IMMUNOGLOBULIN G1, ANTI-(HUMAN CLAUDIN-18.2) (HUMAN-MUS MUSCULUS MONOCLONAL IMAB362 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL IMAB362 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CLDN18 (CLAUDIN 18, CLAUDIN-18, SFTPJ, SURFACTANT ASSOCIATED PROTEIN J) ISOFORM 2, EXTRACELLULAR DOMAIN 1 (EC1)), CHIMERIC MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-448) (MUS MUSCULUS VH (IGHV1-61*01 (92.90%) -(IGHD) -IGHJ2*01) (8.8.11) (1-118) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 (CH1 R120 (215) (119-216), HINGE (217-231), CH2 (232-341), CH3 E12 (357), M14 (359) (342-446), CHS (447-448)) (119-448)), (221-220')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-220') (MUS MUSCULUS V-KAPPA (IGKV8-19*01 (100.00%) -IGKJ4*01) (12.3.9) (1'-113') -HOMO SAPIENS IGKC*01, KM3 A45.1 (159), V101 (197) (114'-220')); DIMER (227-227'':230-230'')-BISDISULFIDE

ZOLBETUXIMAB [INN]

ZOLBETUXIMAB [JAN]

ZOLBETUXIMAB [USAN]

ZOLBETUXIMAB [WHO-DD]

ZOLBETUXIMAB CLZB [WHO-DD]